Discontinuation of antihypertensive medication
Pro Research Analysisby 
Searched over 200M research papers
Risks and Consequences of Abrupt Discontinuation of Antihypertensive Medication
Abruptly stopping antihypertensive medications can lead to a withdrawal syndrome, especially with centrally acting agents (like clonidine, alpha-methyldopa) and beta-blockers. Symptoms may include agitation, headache, sweating, nausea, and, less commonly, rapid increases in blood pressure. In patients with ischemic heart disease, sudden discontinuation of beta-blockers can worsen cardiac conditions. The risk is higher when stopping high doses or combinations of antihypertensive drugs. To prevent these issues, gradual dose reduction is recommended rather than sudden cessation, and patients should be educated about the risks of stopping medication abruptly Garbus1979Houston1981.
Safety of Temporary Discontinuation in Controlled Settings
Temporary discontinuation of antihypertensive medication, such as for diagnostic purposes, is generally safe in well-monitored, specialized hospital settings. Most patients tolerate the discontinuation well, with only a minority experiencing mild or moderate symptoms. The risk of major cardiovascular events does not appear to increase when proper protocols and monitoring are in place .
Long-Term Discontinuation: Success Rates and Predictors
A significant proportion of patients can remain normotensive after stopping antihypertensive medication, especially if they were on monotherapy, had lower blood pressure before withdrawal, and lower body weight. However, the likelihood of maintaining normal blood pressure decreases over time: about 38-40% remain normotensive at 6-12 months, and only about 26% at two years or longer. Adverse events after withdrawal are usually minor, such as headache or palpitations. Regular blood pressure monitoring is essential for those attempting withdrawal Van Der Wardt2017Lee2023.
Discontinuation in Older Adults
In older adults, discontinuing antihypertensive medication may result in little to no difference in mortality, hospitalizations, or stroke compared to continuing medication, but may lead to a modest increase in blood pressure. The evidence is of low certainty, and the effect on myocardial infarction and adverse drug reactions is unclear. Some patients may need to restart therapy due to rising blood pressure or other clinical reasons. More research is needed, especially in frail older adults and those on multiple medications Gnjidic2025Reeve2017.
Patterns and Factors Associated with Discontinuation
Discontinuation rates are high, especially in the first year after starting antihypertensive therapy. About 20-29% of patients stop their medication within the first 6-12 months, and many do not switch to another drug class. Discontinuation is more likely with certain drug types (e.g., diuretics), in younger patients, women, those without comorbidities, and those living in metropolitan areas. Side effects and lack of insurance coverage also increase the likelihood of stopping medication. Conversely, older age, male sex, comorbid conditions, and co-treatment with antidiabetic drugs are linked to better persistence Burke2006Mancia2014Grégoire2002.
Clinical Recommendations
- Abrupt discontinuation should be avoided, especially with centrally acting agents and beta-blockers; gradual tapering is safer Garbus1979Houston1981.
- Temporary discontinuation for diagnostic purposes is generally safe in controlled environments .
- Some patients, particularly those with well-controlled blood pressure on monotherapy, may successfully stop medication, but regular monitoring is crucial Van Der Wardt2017Lee2023.
- In older adults, stopping antihypertensives may not significantly affect major outcomes, but blood pressure should be closely watched Gnjidic2025Reeve2017.
- Clinicians should consider patient-specific factors, educate patients about risks, and monitor closely after discontinuation.
Conclusion
Discontinuation of antihypertensive medication can be safe for selected patients under careful supervision, but abrupt cessation—especially of certain drug classes—can cause significant adverse effects. Patient education, gradual dose reduction, and regular monitoring are key to minimizing risks and ensuring optimal outcomes.
Sources and full results
Most relevant research papers on this topic